Clinical Trials Browser

Phase 1/2 × Castrate Resistant Prostate Cancer × Clear all

NCT01352208 2014-03-24

Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) Patients

Phase 1/2 Terminated

Castrate Resistant Prostate Cancer